News | May 18, 2026
Glenmark Pharma introduces Vancomycin Injection in U.S. market
The product is bioequivalent and therapeutically equivalent to the reference listed drug by Fresenius Kabi USA, LLC.
The product is bioequivalent and therapeutically equivalent to the reference listed drug by Fresenius Kabi USA, LLC.
Dr. Reddy’s is the first company to receive Health Canada approval for generic Semaglutide Injection in Canada
The certification follows an inspection conducted by the Malta Medicines Authority between January 29, 2026, and February 3, 2026
Famotidine Injection USP is a generic version of Pepcid injection to be manufactured at its Nagpur facility for the U.S. market
Darolutamide Tablets, 300 mg, had an estimated market size of US$ 3,155 million in the United States
The state has received Rs. 84,000 crore investments in the sector over two years, positioning Hyderabad among the world’s leading life sciences clusters
Backed by Semaglutide launches, the company reported 47% quarter-on-quarter revenue growth in Q4 FY26, with EBITDA expanding more than fivefold
The target reach is of more than 30 million young people and caregivers across 21 countries
Global specialty pipeline accelerates growth
Nearly one in five women worldwide are now living with obesity
Subscribe To Our Newsletter & Stay Updated
